{"title":"Cerebral Compression Disrupts the Blood-Brain Barrier via Claudin-5 Ubiquitination in the Rat Somatosensory Cortex.","authors":"Tzu-Yin Yeh, Pei-Hsin Liu","doi":"10.1177/09226028261505241","DOIUrl":"https://doi.org/10.1177/09226028261505241","url":null,"abstract":"<p><p>We previously identified blood-brain barrier (BBB) breakdown as a prominent short-term pathological change following epidural compression of the rat somatosensory cortex, and this effect can be prevented by antioxidant treatment. However, the underlying mechanisms remain unclear. Based on prior <i>in vitro</i> studies implicating phosphorylation, ubiquitination, and redistribution of endothelial tight junction proteins in BBB disruption, we hypothesized that similar mechanisms contribute to BBB breakdown in our animal model of epidural compression. Immunoblotting showed that the expression levels of claudin-5, occludin, and JAM-1 were unchanged at 3 days post-compression, although we previously reported that BBB disruption was evident at this time point. Antioxidant treatment selectively increased claudin-5 expression, whereas occludin and JAM-1 levels remained unchanged. Immunoprecipitation and subcellular fractionation analyses demonstrated that 3-day compression markedly increased the phosphorylation and ubiquitination of claudin-5 in both cytosolic and membrane fractions of endothelial cells. Ascorbate not only prevented claudin-5 phosphorylation and ubiquitination but also increased its abundance in the membrane fraction. Epsin1, Eps15, and Hrs are adaptor proteins involved in endocytosis and intracellular trafficking of membrane proteins. Accordingly, we examined their interactions with claudin-5 and found that these interactions were significantly enhanced following compression. Ascorbate attenuated the interactions of claudin-5 with Epsin1 and Eps15, but not with Hrs. Collectively, these findings indicate that epidural compression disrupts BBB primarily by inducing phosphorylation, ubiquitination, and redistribution of claudin-5. This study highlights the therapeutic potential of targeting superoxide during the early phase of cortical compression, particularly under conditions associated with BBB compromise.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"9226028261505241"},"PeriodicalIF":1.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149380582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaoyan Zhang, Yao Tian, Changren Li, Muyang Li, Zhenxing Wang
{"title":"Creutzfeldt-Jakob Disease in the Era of Diagnostic Triumph and Therapeutic Defeat: A Perspective from the Bedside.","authors":"Xiaoyan Zhang, Yao Tian, Changren Li, Muyang Li, Zhenxing Wang","doi":"10.1177/09226028261488180","DOIUrl":"10.1177/09226028261488180","url":null,"abstract":"<p><p>Creutzfeldt-Jakob disease (CJD) exemplifies a cruel paradox of modern neurology: we can now diagnose it with near-perfect accuracy within hours, yet we cannot alter its invariably fatal course. The advent of cerebrospinal fluid (CSF) and skin real-time quaking-induced conversion (RT-QuIC), coupled with high-specificity brain MRI, has enabled robust ante-mortem diagnostic support for CJD, which was previously only definitively established post-mortem. Yet no disease-modifying therapy exists. Drawing on a molecularly supported case of sporadic CJD, this Perspective argues that the widening gap between diagnostic precision and therapeutic impotence is not merely a failure of prion medicine-it is a stress test for the entire rare-disease ecosystem. We examine how this diagnostic triumph creates an unprecedented opportunity for presymptomatic intervention, ultra-adaptive clinical trials, and synergistic combination therapies, and we propose a strategic roadmap to ensure that the next patient diagnosed within hours has a chance, however slim, of a different outcome.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"534-539"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148970844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuroprotective Effects of <i>Moringa Peregrina</i> Leaf Alcoholic Extract on Compression Model of Spinal Cord Injury in Rats.","authors":"Mohammad Hassan Tajik, Mohammad-Reza Delnavazi, Maedeh Hashemi, Morteza Gholaminejhad, Neda Ghaffari, Maryam Shabani, AmirMohammad RezaeiRashnoudi, Kobra Mehrania, Gholamreza Hassanzadeh","doi":"10.1177/09226028261441206","DOIUrl":"10.1177/09226028261441206","url":null,"abstract":"<p><p>BackgroundSpinal cord injury (SCI) is a devastating condition characterized by inflammation, oxidative stress, and neuronal damage. These factors contribute significantly to the secondary injury phase, exacerbating tissue degeneration and impairing recovery. While many therapeutic approaches focus on reducing these detrimental processes, the use of natural products like <i>Moringa peregrina</i> (M.P), a plant known for its antioxidant and anti-inflammatory properties, remains underexplored. This study investigates the neuroprotective effects of the alcoholic extract of <i>Moringa peregrina</i> leaves on SCI, evaluating its impact on oxidative stress, inflammation, and both structural and functional recovery.Materials and MethodsIn this study, fifty-four male Wistar rats were randomly assigned to three groups: laminectomy (sham), SCI (injection of saline intraperitoneally for 21 days), and SCI + <i>Moringa peregrina</i> (150 mg/kg of M.P extract injected intraperitoneally for 21 days). Motor function was assessed using the Basso, Beattie, and Bresnahan (BBB) scale throughout the study period. At 21 days post-injury, we measured the activity of antioxidant enzymes (superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GPx], total antioxidant capacity [TAC]), the oxidative stress marker malondialdehyde (MDA), and inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-18), alongside nuclear factor kappa B (NF-κB). Histological analyses were performed using hematoxylin and eosin (H&E) and cresyl violet staining to evaluate neuronal damage and tissue density.ResultsIntraperitoneal administration of <i>Moringa peregrina</i> extract significantly reduced the levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-18) and the oxidative stress marker MDA, while enhancing the activity of SOD, GPx, CAT, and TAC. These changes were associated with a marked reduction in NF-κB expression. Histological analysis revealed less cellular damage and increased tissue density in the SCI + <i>Moringa peregrina</i> group compared to the SCI group, indicating preserved neuronal structure. Furthermore, motor function recovery was significantly improved in the SCI + <i>Moringa peregrina</i> group, as evidenced by higher BBB scores compared to the untreated SCI group.ConclusionThe findings of this study demonstrate that the alcoholic extract of <i>Moringa peregrina</i> leaves exerts neuroprotective effects through modulation of oxidative stress, inflammation, and structural preservation. The improvement in both motor function and spinal cord tissue integrity highlights the potential therapeutic value of <i>Moringa peregrina</i> in the treatment of SCI.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"444-454"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147842218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carolina Maria Oletto, Francesco Costalunga, Eric Altieri, Cecilia Pugliese, Luca Semenzato, Sara Errigo, Davide Cantavenera, Luca Battaglini
{"title":"Complementary Visual Assessment: Validation of a High-Precision Eye-Tracking Kinetic Perimetry in the Evaluation of Visual Field Deficits in Hemianopia.","authors":"Carolina Maria Oletto, Francesco Costalunga, Eric Altieri, Cecilia Pugliese, Luca Semenzato, Sara Errigo, Davide Cantavenera, Luca Battaglini","doi":"10.1177/09226028261480542","DOIUrl":"10.1177/09226028261480542","url":null,"abstract":"<p><p>Vision is a multicomponential system where different aspects of visual processing rely on distinct neural circuits. This fundamental characteristic has profound implications for how we assess visual field defects. Classical gold standard perimetry focuses primarily on contrast detection. However, the size of the scotoma could be different when measured with kinetic perimetry since motion detection relies on different neural networks. Therefore, we developed and validated a high-precision eye-tracking kinetic perimetry as a complementary tool for evaluating visual field deficits in hemianopia. We emphasized methodological transparency and precise measurement of the transition zone between sighted and blind areas. Thirty-seven participants (17 with retrochiasmal lesions and 20 healthy controls) underwent test-retest evaluation using a kinetic perimetry system integrated with a Tobii Pro Spectrum eye tracker (0.03° RMS precision, 0.3° accuracy, 600 Hz sampling rate). Results demonstrated excellent test-retest reliability with adjusted ICC values exceeding 0.90 across all conditions. The application of an algorithm (LOESS) for noise reduction further improved measurement stability, with ICC increasing to 0.996 for controls and 0.988 for patients, while reducing standard deviation of errors from 4.69° to 1.52° in the affected visual field of patients. Based on these findings, we propose that a visual field enlargement exceeding 5° can be considered a meaningful change beyond the measurement variability of our perimetry. By embracing methodological transparency, including detailed disclosure of eye-tracking specifications and error measurements, and recognizing the multicomponential nature of vision, we aim to contribute to the understanding of visual field defects and their potential for recovery.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"465-476"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148881566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Investigation of the Efficacy of Stem Cell Therapy in a Rat Model of Cyclophosphamide-Induced Neurotoxicity.","authors":"Javid Sardarzada, Aytaj Jafarzade, Elvan Anadol, Durmuş Burgucu, Canan Yilmaz, Semih Ergişi, Muzaffer Çaydere, Tamer Mungan","doi":"10.1177/09226028261470927","DOIUrl":"10.1177/09226028261470927","url":null,"abstract":"<p><p>ObjectiveCyclophosphamide (CYP) is one of the chemotherapeutic agents known to cause neurotoxicity. The aim of this study was to experimentally investigate the potential therapeutic effect of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in the prevention of CYP-related neurotoxicity.MethodsA total of 18 rats were divided into three groups: Group 1: CYP, Group 2: CYP + stem cell, Group 3: control. Groups 1 and 2 received intraperitoneal (IP) CYP for 14 days, while the control group received IP saline. Subsequently, hUC-MSCs were administered to Group 2 as treatment. Mesenchymal stem cell (MSC) treatment was initiated only after completion of cyclophosphamide (CYP) administration to induce neurotoxicit. At the end of the first month, the animals were euthanized. Brain tissues were collected and examined using H&E, neurofilament immunostaining, and silver nitrate staining. Neurodegeneration and regeneration in the cerebral and cerebellar cortices were evaluated in a blinded histopathological manner. Histopathological evaluation of degeneration in the cerebral and cerebellar cortex, as well as cerebral gliosis, was performed and graded between 1 and 4 (0-25%: grade 1, 25-50%: grade 2, 50-75%: grade 3, 75-100%: grade 4).ResultsIn the CYP group (Group 1), degeneration in the cerebral and cerebellar cortex and a higher number of cerebral glial cells were significantly higher compared to the other groups (<i>p</i> < 0.001; <i>p</i> < 0.001; <i>p</i> < 0.001). In Group 2 (CYP + stem cell), evidence of regeneration was observed in the cerebral and cerebellar cortex, along with a reduction in cerebral glial cells (<i>p</i> < 0.001). The results of the stem cell-treated group were closer to those of the control group.ConclusionhUC-MSCs demonstrated a neuroprotective effect against CYP-induced neurotoxicity. Stem cell therapy may represent a promising approach to prevent the neurodegenerative effects of cytotoxic agents.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"455-464"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148697959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of Intrinsic Feedback-Based Gait Training Under Visual Deprivation on Balance and Gait in Stroke Survivors: A Randomized Controlled Study.","authors":"Myunggi Cho","doi":"10.1177/09226028261495203","DOIUrl":"10.1177/09226028261495203","url":null,"abstract":"<p><p>Feedback is an essential component of motor learning and rehabilitation. Although extrinsic feedback is widely used in stroke rehabilitation, excessive dependence on external cues may limit opportunities for independent movement regulation. Training that emphasizes intrinsic feedback during visual deprivation (VD) may provide individuals with greater opportunities to perceive and regulate their movements using internally available sensory information. This study investigated the effects of gait training with intrinsic feedback on balance and gait abilities in individuals with stroke compared with extrinsic feedback training and conventional physical therapy. Thirty-six individuals with stroke were randomly assigned to the gait training with intrinsic feedback (GIF) group, gait training with extrinsic feedback (GEF) group, or control group (CG). The GIF performed forward and backward linear and curvilinear gait tasks on stable and unstable surfaces during VD without continuous verbal guidance. The GEF performed the same gait tasks during VD while receiving continuous verbal guidance, whereas the CG received conventional physical therapy. All interventions were conducted for 30 min, five times per week, for 8 weeks. Outcome measures included the Four Square Step Test (FSST), weight distribution, spatiotemporal gait variables, center of pressure (COP) variables, and the 10-Meter Walk Test (10 MWT). Significant group × time interactions were observed for the FSST, weight distribution, gait velocity, cadence, paretic stance phase, paretic swing phase, paretic step time, stride time, and the 10 MWT (p < 0.05). The GIF demonstrated significantly greater improvements than both the GEF and CG in the FSST, gait velocity, cadence, paretic step time, stride time, and the 10 MWT (p < 0.05). The GIF also showed greater improvement than the CG in weight distribution (p < 0.05). These findings suggest that gait training emphasizing intrinsic feedback during VD may provide additional benefits for selected aspects of balance and gait performance in individuals with stroke.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"522-533"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149166983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Svenja Rink-Notzon, Martin Krueger, Milen Zamfirov, Muthuraman Muthuraman, Diana Schaufler, Levent Sarikcioglu, Süreyya Bilmen, Johannes Vogt, Heiko Endle, Lyudmila Belenska-Todorova, Stoyan Pavlov, Maria Eleni Manthou, Doychin N Angelov
{"title":"Whole-Body Vibration After Compressive Spinal Cord-Injury in Rats Restores Dorsal Horn Synaptic Relations and Alleviates Pain-Associated Behavior.","authors":"Svenja Rink-Notzon, Martin Krueger, Milen Zamfirov, Muthuraman Muthuraman, Diana Schaufler, Levent Sarikcioglu, Süreyya Bilmen, Johannes Vogt, Heiko Endle, Lyudmila Belenska-Todorova, Stoyan Pavlov, Maria Eleni Manthou, Doychin N Angelov","doi":"10.1177/09226028261464314","DOIUrl":"10.1177/09226028261464314","url":null,"abstract":"<p><p>Spinal cord injury (SCI) induces neuronal loss and demyelination, leading to maladaptive neuronal circuits that drive persistent central neuropathic pain (PCNP). While pharmacological, psychological, and physiotherapeutic approaches have been applied, including whole-body vibration (WBV), synaptic-level mechanisms of WBV remain largely unexplored. Here, we assessed the post-SCI pain-associated behavior index (PAB, based on established behavioral criteria) and compared synapse counts (SYN+, VGLUT1+, ChAT+, VGAT+), CGRP+- and SER+-structures, as well as astrocytic and microglial populations in the lumbar dorsal horn following thoracic SCI in WBV-treated and untreated rats. Animals received WBV from postoperative week 3 to 12, and outcomes were compared with non-treated controls. PAB was consistently reduced in WBV-treated animals. STED-microscopy quantification showed that WBV increased the linear density of VGAT + and VGLUT1 + perisomatic terminals, as well as the number of SER + fibers. Conversely, WBV reduced CGRP + structures in the dorsal horn, decreased the density of CGRP + perisomatic and axo-axonic synapses, and lowered astrocytic and microglial populations. Our data indicate that the WBV-induced frequent (15-30 Hz) muscle contractions and proprioceptive impulses contribute to spasticity modulation (via VGAT-related mechanisms) and attenuation of post-SCI hyperalgesia (CGRP-associated). Together with the reduced astro- and microglia amounts, the described synaptic alterations are considered essential prerequisites for better motor recovery. These findings provide preclinical evidence for the functional benefits of WBV in an animal SCI model and warrant further investigations to determine mechanisms underpinning this non-invasive, low-cost and easily applicable rehabilitation approach.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"488-521"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Resveratrol Maintains Hippocampal Mitochondrial Function and Inhibits Neuronal Ferroptosis to Improve Diabetes-Associated Cognitive Dysfunction via Sirt1/Shh Signaling.","authors":"Ying Hu, Jiancheng Wang, Jiao Wang, Yuanyuan Deng, Wen Chen, Qin Zhang","doi":"10.1177/09226028261485654","DOIUrl":"10.1177/09226028261485654","url":null,"abstract":"<p><p>BackgroundResveratrol has been shown to play a neuroprotective role in diabetic cognitive dysfunction. We determined whether resveratrol improved diabetic cognitive dysfunction through ferroptosis regulation, and explored the potential mechanism.MethodsRats were fed with a high-sucrose and high-fat diet combined with streptozotocin for establishing a diabetic model, followed by resveratrol treatment with or without erastin (a classical ferroptosis activator). Cognitive abilities were evaluated with novel object recognition test and Morris water maze test. Neuronal damage was determined using Nissl staining and Fluoro-Jade B staining. Ferroptosis-related factors such as glutathione (GSH), 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS) and iron (Fe<sup>2+</sup>) levels were evaluated. Mitochondrial function was assessed by mitochondrial morphology, mitochondrial swelling, mitochondrial membrane potential (MMP), and ATP content. Western blot was performed to measure Sirtuin 1 (Sirt1) and Sonic hedgehog (Shh) signaling pathway, and ferroptosis-related proteins. Besides, the cellular localization of Sirt1 and Shh was assessed using immunofluorescence.ResultsResveratrol ameliorated cognitive dysfunction and neuronal damage in diabetic rats and blocked hippocampal neuron ferroptosis, which were abolished by erastin. Resveratrol ameliorated hippocampal mitochondrial dysfunction (decrease of mitochondrial swelling and increases of MMP and ATP) in diabetic rats. Resveratrol treatment upregulated Sirt1 and Shh expressions in NeuN-positive neurons in the hippocampus of diabetic rats. Moreover, Shh knockdown reversed the protective effects of resveratrol on ferroptosis, cognitive dysfunction, and neuron loss.ConclusionResveratrol conferred neuroprotective effect on diabetic cognitive dysfunction by maintaining mitochondrial function and inhibiting hippocampal neuron ferroptosis via Sirt1/Shh signaling.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"427-443"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Purposeful Activity-Based Electrical Stimulation Improves Activities of Daily Living in Patients with Subacute Stroke and Moderate-to-Severe Upper Limb Hemiparesis: A Pilot Randomised Controlled Trial.","authors":"Seigo Minami, Yoshihiro Fukumoto, Ryuji Kobayashi, Hideaki Aoki, Takahiro Horaguchi, Kenji Takeuchi, Kengo Yoshihara, Mitsumasa Hida, Tomoki Aoyama","doi":"10.1177/09226028261481873","DOIUrl":"10.1177/09226028261481873","url":null,"abstract":"<p><p>PurposeIn this randomised controlled trial study, we aimed to preliminarily evaluate the effectiveness of purposeful activity-based electrical stimulation therapy (PA-EST) in improving independence in daily living in patients with stroke and moderate-to-severe upper limb hemiparesis.MethodsThis study was conducted in the rehabilitation ward of Kyoto Ohara Memorial Hospital, Japan. Sixteen rehabilitation ward inpatients who experienced stroke and moderate-to-severe upper limb hemiparesis were included. In this randomised controlled trial, the participants were randomly assigned to either PA-EST or conventional occupational therapy (COT) and received a 2-month intervention. The primary outcome measures included motor, cognitive, and total scores on the functional independence measure (FIM). The secondary outcome measures included the Motor Activity Log (MAL), Amount of Use and Quality of Movement (QOM) subscales, and the Upper Extremity, Lower Extremity, and Total Fugl-Meyer Assessment scores.FindingsTwo-way repeated measures analysis of variance revealed significant interactions for FIM-motor (p = 0.041), FIM-total (p = 0.029), and MAL-QOM (p = 0.005), with greater improvements in the PA-EST group than in the COT group. No significant interactions were observed for the other outcome measures.ConclusionsThis randomised controlled trial study provides preliminary evidence that PA-EST may enhance activities of daily living independence in patients with subacute-phase stroke and moderate-to-severe upper limb hemiparesis. These findings support the clinical utility of PA-EST as a novel intervention strategy for advancing stroke rehabilitation.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"477-487"},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniela Yazmin Velázquez-Colin, William Yahir Hernández-Tenorio, Alexis Brandon Cruz-Cruz, Maritza Estrada, Stefany Jeovanna Téllez-Reyes, Melchor Castro-Marín, Exsal Manuel Albores-Méndez, Ivan Ignacio-Mejía, Antonio Ibarra
{"title":"The Use of Nutritional Supplements as a Therapy for Spinal Cord Injury. A Narrative Review.","authors":"Daniela Yazmin Velázquez-Colin, William Yahir Hernández-Tenorio, Alexis Brandon Cruz-Cruz, Maritza Estrada, Stefany Jeovanna Téllez-Reyes, Melchor Castro-Marín, Exsal Manuel Albores-Méndez, Ivan Ignacio-Mejía, Antonio Ibarra","doi":"10.1177/09226028261501423","DOIUrl":"https://doi.org/10.1177/09226028261501423","url":null,"abstract":"<p><p>AimTo evaluate the therapeutic potential of nutritional supplementation as a complementary strategy to mitigate secondary injury mechanisms and promote recovery in spinal cord injury (SCI).MethodsThis narrative review synthesizes current preclinical and clinical evidence on the role of micronutrients and macronutrients in SCI management, focusing on their mechanisms of action in neuroprotection, neuroregeneration, and functional recovery.ResultsSCI is a severe neurological condition characterized by long-term motor, sensory, and autonomic dysfunction, largely driven by secondary injury processes such as oxidative stress, neuroinflammation, excitotoxicity, and apoptosis. Evidence indicates that micronutrients-including vitamins A, B complex, C, D, and E, as well as trace elements such as selenium, zinc, copper, and magnesium-exert neuroprotective effects by modulating inflammatory responses, reducing oxidative damage, supporting mitochondrial function, and enhancing myelination. Additionally, macronutrients such as carbohydrates, amino acids, omega-3 fatty acids, and bioactive compounds including alpha-lipoic acid, N-acetylcysteine, and acetyl-L-carnitine contribute to axonal regeneration, metabolic support, and functional recovery. Collectively, these nutrients target key pathophysiological pathways involved in secondary SCI progressionConclusionsNutritional supplementation represents a promising, safe, and accessible adjunctive strategy to enhance neuroprotection and improve outcomes in individuals with SCI. However, further research is required to optimize dosing, timing, and combinatorial approaches to maximize therapeutic efficacy.</p>","PeriodicalId":21130,"journal":{"name":"Restorative neurology and neuroscience","volume":" ","pages":"9226028261501423"},"PeriodicalIF":1.8,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}